Axis Bank (NSE:AXISBANK, BOM:532215) has invested an additional 3.81 billion Indian rupees in the equity shares of Axis Max Life Insurance Company, according to a Monday filing to the Indian stock exchanges.
Following the investment, the shareholding of the lender and its subsidiaries, Axis Securities Limited and Axis Capital, will increase to 19.99% from 19.02%.
4DMedical (ASX:4DX) launched CLEAR, a clinical evidence program designed to accelerate entry of its CT:VQ imaging technology into the acute pulmonary embolism market, targeting a $3 billion obtainable market in the US, according to a Tuesday Australian bourse filing.The company said the core CLEAR study, which stands for Contrast-free Lung Evaluation for Acute Risk in pulmonary embolism, is a multi-center, multinational, prospective, observational study putting CT:VQ head-to-head with computed tomography pulmonary angiography in patients with suspected pulmonary embolism, the filing added.4DMedical has entered into a clinical research agreement with Mass General Brigham-affiliated teaching hospitals as the lead site for CLEAR, it added.
Kioxia (TYO:285A) is seeking to recover lost market share by commercializing a new technology ahead of its competitors such as Samsung Electronics (KRX:005930), Nikkei Asia reported Tuesday, citing the company's engineer.The plan comes as rising demand for data center memory extends to NAND flash chips, the report said.The company is set to hold its first investor strategy briefing in a year on Tuesday, where Kioxia is expected to outline its technology roadmap, according to Nikkei.While Kioxia's predecessor Toshiba, pioneered vertical stacking technology for NAND in 2007, the company has recently lagged behind rivals in layer counts-its main products still use 218 layers, compared to SK Hynix's (KRX:000660) 300-plus-layer chip unveiled in summer 2023, the publication said.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
KITZ (TYO:6498) has finalized the acquisition of all shares of V TEX, turning the industrial special valve and rupture disk manufacturer into a fully owned subsidiary, according to a Tokyo bourse filing on Monday.The transaction involved purchasing 886,400 shares for nearly 9.2 billion yen, with total costs including advisory fees reaching around 9.37 billion yen.Following the acquisition, an extraordinary general meeting of V TEX shareholders approved the appointment of new directors and corporate auditors, leading to a restructured management team that includes Kenji Kato as President & CEO.Several new appointees, such as part-time director Tomoya Maekawa and part-time corporate auditors Toshiyuki Murasawa and Kenichi Bessho, will concurrently hold positions at KITZ.V TEX will be consolidated into KITZ's financial statements starting from the second quarter of the fiscal year ending December, with any material impact on results to be disclosed later.